Lung Non-Squamous Non-Small Cell Carcinoma

Lung Non-Squamous Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

408 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 93
Recruiting: 47
Ph III recruiting: 15
Growth YoY: —
Industry share: 39%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (55)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01066884	A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer	completed	Phase 4	5	Hoffmann-La RocheINDUSTRY	1	Aug 24, 2016	clinicaltrials
NCT00451906	A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.	completed	Phase 4	2,252	Hoffmann-La RocheINDUSTRY	40	May 24, 2016	clinicaltrials